Breast Cancer Clinical Trial

Normal Tissue Oxygenation Following Radiotherapy

Summary

This study involves women who have had a diagnosis of breast cancer, and have had a lumpectomy with radiation treatments completed in the past year.

The study will determine the level of oxygen in the skin of the breast that has been radiated, compared with the normal skin of the opposite breast.

The purpose of this study is to determine if there is a decrease in oxygen levels in the skin which has been radiated, hopefully to find a treatment to limit skin damage caused by radiation treatments, for women with breast cancer in the future.

View Full Description

Full Description

Successful completion of this study will provide data on changes in oxygenation in irradiated tissues. If changes are documented, this study would provide evidence supporting current models of tissue injury following radiotherapy. In addition, these data may provide a mechanistic rationale for clinical approaches to ameliorate the toxicities of radiotherapy. Finally, if a correlation exists between tissue oxygenation and toxicity, the rapid and simple tissue oxygenation test may provide a quantitative measure of toxicity and allow earlier and more precise assessment of both toxicity and efficacy of ameliorative therapies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of breast malignancy
Completion of breast irradiation one year (+/- 8 weeks) prior.
Surgical treatment with lumpectomy

Exclusion Criteria:

Inability to tolerate the 20 minute transcutaneous oxygenation measurements
Allergy to adhesives
Bilateral disease or absence of control breast or previous radiotherapy to "control" breast
More than one course of radiotherapy to the breast

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT00677040

Recruitment Status:

Completed

Sponsor:

Essentia Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Essentia Health
Duluth Minnesota, 55805, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT00677040

Recruitment Status:

Completed

Sponsor:


Essentia Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider